Lecap Asset Management Ltd. Takes $564,000 Position in Xylem Inc. $XYL

Lecap Asset Management Ltd. bought a new position in Xylem Inc. (NYSE:XYLFree Report) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 4,357 shares of the industrial products company’s stock, valued at approximately $564,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of XYL. Vanguard Group Inc. boosted its position in shares of Xylem by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock valued at $3,465,122,000 after acquiring an additional 362,127 shares in the last quarter. Swedbank AB lifted its stake in Xylem by 13.9% during the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after purchasing an additional 531,890 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Xylem by 7.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock valued at $480,767,000 after purchasing an additional 274,123 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Xylem by 689.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock valued at $443,074,000 after purchasing an additional 3,239,203 shares during the period. Finally, Northern Trust Corp raised its holdings in shares of Xylem by 2.9% in the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after buying an additional 94,560 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on XYL shares. Zacks Research upgraded Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. UBS Group upped their target price on shares of Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a report on Tuesday, August 5th. Mizuho lifted their price target on shares of Xylem from $125.00 to $140.00 and gave the company a “neutral” rating in a report on Friday, September 12th. Cowen restated a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. Finally, Wall Street Zen raised shares of Xylem from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $152.33.

View Our Latest Stock Analysis on Xylem

Insider Buying and Selling at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the transaction, the chief accounting officer owned 2,957 shares of the company’s stock, valued at $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is currently owned by insiders.

Xylem Stock Up 0.8%

Shares of NYSE:XYL opened at $149.02 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The firm has a market cap of $36.27 billion, a P/E ratio of 38.71, a P/E/G ratio of 2.56 and a beta of 1.13. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $149.93. The company’s 50-day moving average price is $141.61 and its two-hundred day moving average price is $129.23.

Xylem (NYSE:XYLGet Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.15 by $0.11. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. Xylem’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, research analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s dividend payout ratio (DPR) is 41.56%.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.